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Correspondence
Response to Letters Regarding Article, “Lower
Mortality from Coronary Heart Disease and
Stroke at Higher Altitudes in Switzerland”
We thank the authors of the two letters for their interest and their
comments. Dr Sullivan et al refer to the erythropoietic adaptations
and changes in iron metabolism that occur when subjects are exposed
to high altitudes (up to over 4500 m above sea level) and thus to
extreme conditions.1,2 However, the population included in our study
lived at altitudes below 2000 m, and more than 98% lived below
1200 m.3 On the basis of the available literature, it appears unlikely
that the adaptations described occur at such relatively low alti-
tudes.2,4 Accordingly, it cannot be expected that the effects described
substantially contribute to lower cardiovascular mortality at higher
altitudes in Switzerland.
We do not know whether the risk of diabetes mellitus decreases
with increasing altitude because there are no nationwide data on the
incidence or prevalence of type 2 diabetes mellitus in Switzerland.
However, the data from the Swiss Health Survey 2002 used for our
article also provide self-reported information on the diabetes mellitus
status of participants.3 We calculated the prevalence of self-reported
diabetes mellitus and found no significant differences between the
altitudinal belts. The prevalence of self-reported diabetes mellitus
was at altitudes300 m, 5.8% (95% Confidence interval [CI]: 4.6 to
7.0); 300 to 600 m, 3.8% (CI: 3.4 to 4.2); 600 to 900 m, 3.4% (CI:
2.6 to 4.3); 900 to 1200 m, 4.0% (CI: 1.8 to 6.2); 1200 to 1500 m,
4.3% (CI: 0.1 to 8.5); 1500 m, 5.1% (CI: 0.7 to 9.5). The high
prevalence at 300 m could be explained by the fact that most
inhabitants at that altitude live in the city of Basel, which has the
highest density of practitioners in Switzerland. It can thus be
speculated that a higher proportion of patients with type 2 diabetes
mellitus is being detected than at altitudes with a less urban
population. Although self-reported health survey data have limited
validity, we would not expect that, in Switzerland, altitudinal
differences in the prevalence of diabetes mellitus are large enough to
influence variations in cardiovascular mortality. As shown in the
online supplement to our article, there was no significant difference
between altitudes in potential risk factors for diabetes mellitus
(obesity, cigarette smoking, physical inactivity, infrequent fruit
consumption).3 By contrast, in Tyrol, the prevalence of obesity and
physical inactivity was lower than in the rest of the country, which
is in accordance with variations in the incidence of diabetes mellitus
in Austria.5 As already stated in our article, we have no reason to
believe that highlanders constitute a genetically different population,
inasmuch as more than half of them are recent immigrants from
lower regions.3 We cannot imagine other independent mechanisms
related to altitude that could be responsible for differences in the
prevalence of diabetes mellitus. Unfortunately, the study by Wimmer
et al neither discloses whether diabetes mellitus prevalence differed
by altitude within Tyrol or other Austrian mountainous states
(Salzburg, Styria, Carinthia) nor proposes hypotheses for a causal
pathway dependent on altitude.5 However, the lack of data stresses
the need for a valid assessment of geographical variation in diabetes
mellitus in Switzerland and elsewhere.
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